2Gingeras TR,Ghandour G,Wang E,et al.Simutaneous genotyping and species identification using hybridization pattern recognition analysis of generic Mycobacterium DNA arrays[J].Genome Res,1998,8:435-448.
3Debouck C,Goodfellow PN.DNA microarrays in drug discovery and development[J].Nat Genet,1999,21(suppl 1):48-50.
4Barry CE.New horizons in the treatment of tuberculosis[J].Biochem Pharmacol,1997,54:1165-1162.
6Marton MJ,DeRisi JL,Bennett HA,et al.Drug target validation and identification of secondary drug target effects using DNA microarray[J].Nat Med,1998,4:1293-1301.
7Urquhart BL,Atsalos TE,Roach D,et al."Proteomic contigs" of Mycobacterium tuberculosis and Mycobacterium bovis-BCG using novel immobilised pH gradients[J].Electrophoresis,1997,18:1384-1392.
8Bailey DS,Bondar A,Furness LM.Pharmacogenomics--it's not just pharmacogenetics[J].Curr Opin Biotechnol,1998,9:595-601.
9Veber DF,Drake FH,Gowen M.The nwe partnership of genomics and chemistry for accelerated drug development[J].Curr Opin Chem Biol,1997,1:151-156.
10Lipinski CA,Lombardo F.Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings[J].Adv Drug Delivery Rev,1997,23:3-25.
